Position in ONC
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,199,723
-$120,605 QoQ
Shares Held
4,210
-5.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#121
of 282 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. ONC ranks #54 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,398 | $11,622,488 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,444 | $6,512,251 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,814 | $4,158,428 | |
| 4 | MRNA |
Moderna, Inc.
|
33,142 | $2,320,934 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
17,163 | $2,278,044 | |
| 6 | CYTK |
Cytokinetics Inc
|
25,572 | $2,178,478 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
5,770 | $2,144,535 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
18,455 | $2,116,234 |
All Filings in ONC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,199,723 | 4,210 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,320,328 | 4,446 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,426,995 | 4,697 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,986,621 | 5,831 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,147,411 | 4,740 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,413,923 | 5,195 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $847,080 | 4,586 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $991,436 | 4,416 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $681,962 | 4,780 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $932,240 | 5,961 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,158,813 | 6,425 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $927,589 | 5,157 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $795,574 | 4,462 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,104,160 | 5,123 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,162,822 | 5,287 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,291,710 | 9,581 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,466,684 | 9,062 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,608,192 | 8,527 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,402,875 | 5,178 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,180,606 | 8,762 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,992,959 | 8,721 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,070,761 | 8,822 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,018,284 | 7,811 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,471,442 | 5,137 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $791,845 | 4,203 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $557,442 | 4,528 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||